Variable | Surgical group, N (%) | Non Surgical group, N (%) |
---|---|---|
Efficacy evaluation | ||
CR | 1 (4.5) | 0 (0) |
PR | 18 (81.8) | 9 (42.9) |
SD | 3 (13.7) | 0 (0) |
PD | 0 (0) | 7 (57.1) |
Unresectable factors | ||
N3 lymph node metastasis | 2 (9.1) | 0 (0) |
Distant lymphatic metastasis | 2 (9.1) | 2 (12.4) |
Invasion of peripheral organs (T4b) | 3 (13.7) | 1 (6.3) |
Liver metastasis | 1 (4.5) | 1 (6.3) |
Peritoneal carcinomatosis | 14 (63.6) | 12 (75.0) |